<?xml version='1.0' encoding='utf-8'?>
<?xml-stylesheet type="text/xsl" href="/v2/static/oai2.xsl"?>
<OAI-PMH xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2026-10-13T01:20:21Z</responseDate>
  <request identifier="oai:figshare.com:article/33967550" metadataPrefix="oai_dc" verb="GetRecord">https://api.figshare.com/v2/oai</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:figshare.com:article/33967550</identifier>
        <datestamp>2026-09-22T17:40:05Z</datestamp>
        <setSpec>category_1</setSpec>
        <setSpec>category_146</setSpec>
        <setSpec>category_7</setSpec>
        <setSpec>category_12</setSpec>
        <setSpec>category_13</setSpec>
        <setSpec>category_14</setSpec>
        <setSpec>category_16</setSpec>
        <setSpec>category_21</setSpec>
        <setSpec>category_734</setSpec>
        <setSpec>category_61</setSpec>
        <setSpec>category_132</setSpec>
        <setSpec>portal_87</setSpec>
        <setSpec>item_type_3</setSpec>
        <setSpec>month_year_09_2026</setSpec>
      </header>
      <metadata>
        <oai_dc:dc xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance"  xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:dc="http://purl.org/dc/elements/1.1/" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/ http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
          <dc:title>γ-Glutamylcysteine alleviates hypertension and vascular remodeling in SHR by suppressing oxidative stress through Keap1 S-glutathionylation</dc:title>
          <dc:creator>Jianzhen Lei (25091261)</dc:creator>
          <dc:creator>Yueru Kong (25091264)</dc:creator>
          <dc:creator>Chao Ye (765248)</dc:creator>
          <dc:creator>Chuanyue Zhang (22845434)</dc:creator>
          <dc:creator>Yi Shen (152956)</dc:creator>
          <dc:creator>Xin Wu (10164)</dc:creator>
          <dc:creator>Qiuyue Wu (298026)</dc:creator>
          <dc:creator>Ying Han (137520)</dc:creator>
          <dc:creator>Min Chen (147733)</dc:creator>
          <dc:creator>Yueqi Song (7255751)</dc:creator>
          <dc:creator>Qing Yan (72879)</dc:creator>
          <dc:creator>Fen Zheng (10133801)</dc:creator>
          <dc:creator>Xinyi Xia (7516694)</dc:creator>
          <dc:subject>Biophysics</dc:subject>
          <dc:subject>Space Science</dc:subject>
          <dc:subject>Medicine</dc:subject>
          <dc:subject>Cell Biology</dc:subject>
          <dc:subject>Genetics</dc:subject>
          <dc:subject>Molecular Biology</dc:subject>
          <dc:subject>Physiology</dc:subject>
          <dc:subject>Biotechnology</dc:subject>
          <dc:subject>Biological Sciences not elsewhere classified</dc:subject>
          <dc:subject>Developmental Biology</dc:subject>
          <dc:subject>Infectious Diseases</dc:subject>
          <dc:subject>γ-Glutamylcysteine</dc:subject>
          <dc:subject>hypertension</dc:subject>
          <dc:subject>vascular remodeling</dc:subject>
          <dc:subject>vascular smooth muscle cells</dc:subject>
          <dc:subject>phenotypic switching</dc:subject>
          <dc:subject>oxidative stress</dc:subject>
          <dc:subject>Nrf2/Keap1</dc:subject>
          <dc:subject>S-glutathionylation</dc:subject>
          <dc:description>&lt;p&gt;Pathological arterial remodeling heavily depends on the aberrant proliferation and migration of vascular smooth muscle cells (VSMCs). This study explores how &lt;i&gt;γ&lt;/i&gt;-Glutamylcysteine (&lt;i&gt;γ&lt;/i&gt;-GC) regulates VSMC signaling to mitigate hypertensive structural damage.&lt;/p&gt; &lt;p&gt;Spontaneously hypertensive rats (SHR) and Wistar-Kyoto (WKY) rats received intraperitoneal injections of &lt;i&gt;γ&lt;/i&gt;-GC (100 mg/kg) every two days for 4 weeks. Blood pressure and arterial remodeling were evaluated. Primary aortic VSMCs were cultured for cellular mechanism analysis. To verify Nrf2 pathway requirement, the Nrf2 inhibitor ML385 was applied &lt;i&gt;in vitro&lt;/i&gt; and via osmotic pumps &lt;i&gt;in vivo&lt;/i&gt;.&lt;/p&gt; &lt;p&gt;&lt;i&gt;γ&lt;/i&gt;-GC lowered systemic blood pressure and prevented arterial medial thickening in SHR, while normotensive controls remained unaffected. In SHR-VSMCs, &lt;i&gt;γ&lt;/i&gt;-GC inhibited cell migration, proliferation, and phenotypic switching, and alleviated cellular oxidative stress. RNA-seq revealed significant enrichment of the Nrf2 signaling pathway. Mechanistically, &lt;i&gt;γ&lt;/i&gt;-GC induced Keap1 S-glutathionylation, which disrupted the Keap1 and Nrf2 interaction and promoted Nrf2 nuclear translocation. Notably, Nrf2 inhibition with ML385 abolished the protective effects of &lt;i&gt;γ&lt;/i&gt;-GC &lt;i&gt;in vivo&lt;/i&gt; and &lt;i&gt;in vitro&lt;/i&gt;.&lt;/p&gt; &lt;p&gt;&lt;i&gt;γ&lt;/i&gt;-GC attenuates hypertensive arterial remodeling by modulating intracellular signaling, specifically through Keap1 S-glutathionylation-dependent Nrf2 activation. The Keap1/Nrf2 signaling axis is required for &lt;i&gt;γ&lt;/i&gt;-GC to restore VSMC function, suggesting a targeted molecular mechanism for cardiovascular protection.&lt;/p&gt;</dc:description>
          <dc:date>2026-09-22T17:40:05Z</dc:date>
          <dc:type>Dataset</dc:type>
          <dc:type>Dataset</dc:type>
          <dc:identifier>10.6084/m9.figshare.33967550.v1</dc:identifier>
          <dc:relation>https://figshare.com/articles/dataset/_-Glutamylcysteine_alleviates_hypertension_and_vascular_remodeling_in_SHR_by_suppressing_oxidative_stress_through_Keap1_S-glutathionylation/33967550</dc:relation>
          <dc:rights>CC BY 4.0</dc:rights>
        </oai_dc:dc>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
